• Hoechst 33342: Precision Nuclear Staining for Quantitative C

  2026-08-05

  Explore how Hoechst 33342, a bis-benzimidazole fluorescent dye, enables rigorous, quantitative nuclear DNA detection and advanced cell cycle analysis. This article uniquely integrates molecular mechanism, assay optimization, and practical guidance for high-specificity chromatin visualization.

• Naloxone Hydrochloride: Rewiring Opioid Research for Transla

  2026-08-04

  This thought-leadership article examines naloxone hydrochloride's evolving role as a mechanistic probe and translational tool in opioid receptor research. Blending cutting-edge insights—from neural stem cell biology to behavioral models of addiction and withdrawal—this piece provides translational researchers with strategic guidance for optimizing protocols, interpreting data, and bridging preclinical findings to clinical realities. Drawing from recent literature, including the anxiolytic modulation of opioid withdrawal by CCK-8 and the unique features of APExBIO’s high-purity naloxone, we chart the next frontier in opioid system research and its impact on therapeutic innovation.

• IAM LC vs LEKC: Modeling Drug Permeability Across Membranes

  2026-08-04

  This study systematically compares immobilised artificial membrane liquid chromatography (IAM LC) and liposome electrokinetic capillary chromatography (LEKC) as biomimetic tools for predicting drug partitioning and permeability, with a focus on the respiratory mucosa. The findings highlight LEKC's superior capacity in modeling pulmonary drug permeability, while IAM LC offers broader applicability for compounds with diverse lipophilicity.

• Prestained Protein Marker: Triple Color Ladder for SDS-PAGE

  2026-08-03

  Elevate SDS-PAGE and Western blot workflows with the Prestained Protein Marker (Triple color, EDTA free, 10-250 kDa), delivering triple-color, EDTA-free standards for confident protein sizing and transfer verification. Discover protocol optimizations and troubleshooting strategies that streamline translational research, as revealed in recent studies on Streptococcus mutans protein interaction assays.

• N-octanoyl-L-Homoserine Lactone in Pathogenicity Research

  2026-08-03

  N-octanoyl-L-Homoserine lactone (C8-HSL) is transforming microbial pathogenicity research by enabling precise manipulation of bacterial communication and its downstream effects on host cells. This article details applied workflows, troubleshooting strategies, and the latest insights—anchored by a seminal cancer study—that empower infection biology labs to harness C8-HSL for both foundational and translational research.

• Exo1 (methyl 2-(4-fluorobenzamido)benzoate): Precision in Me

  2026-08-02

  Exo1 offers researchers a uniquely selective approach to acutely block membrane trafficking via Golgi-to-ER collapse, enabling ARF1-specific dissection of exocytic pathways without disturbing the trans-Golgi network. This article provides stepwise workflow guidance, troubleshooting tactics, and context on its application in advanced exocytosis and tumor extracellular vesicle (TEV) research.

• Annexin V-Cy5 Apoptosis Kit: Precision Detection in Neuroimm

  2026-08-01

  The Annexin V-Cy5 Apoptosis Kit enables highly sensitive detection of early apoptosis via phosphatidylserine exposure, supporting robust analysis in neuroimmune and lysosomal stress research. Its rapid, single-step fluorescent protocol is validated for both flow cytometry and fluorescence microscopy. This article details the kit’s mechanism, evidence base, and best practices for reliable apoptosis assay workflows.

• Amikacin Sulfate: Innovations in Targeted Therapy for NTM In

  2026-07-31

  Explore the unique pharmacological profile of Amikacin Sulfate, a potent antibiotic for non-tuberculous mycobacterial infections, with a focus on intracellular delivery and safety. This article provides new insights on optimizing therapeutic strategies and assay design, setting it apart from standard protocol guides.

• Cefiderocol Activity Against Resistant European Enterobacter

  2026-07-31

  Santerre Henriksen et al. systematically evaluated cefiderocol’s in vitro efficacy against a large and diverse set of European Enterobacterales, including strains resistant to both meropenem and contemporary β-lactam/β-lactamase inhibitor combinations. Their findings demonstrate cefiderocol’s superior spectrum and underscore the importance of tailored susceptibility testing to guide therapy for multidrug-resistant infections.

• CB-839 (Telaglenastat): Optimizing Cancer Metabolism Researc

  2026-07-30

  CB-839 (Telaglenastat) is redefining glutamine metabolism research with its potent, selective inhibition of GLS1. This article delivers actionable workflows, troubleshooting strategies, and protocol enhancements to advance preclinical cancer drug evaluation using APExBIO’s trusted compound.

• Prosapogenin A Triggers GSDME-Dependent Pyroptosis in ATC vi

  2026-07-30

  This study uncovers how Prosapogenin A induces GSDME-dependent pyroptosis in anaplastic thyroid cancer by hyperactivating vacuolar ATPase and driving lysosomal over-acidification. The findings reveal a novel lysosome-centered cell death mechanism and provide a potential therapeutic avenue for overcoming the aggressive nature of ATC.

• Dietary Arachidonic Acid Enhances Humoral Immunity Post-Vacc

  2026-07-29

  This study demonstrates that dietary arachidonic acid (ARA) supplementation significantly accelerates and amplifies humoral immune responses to rabies vaccination in mice and humans. By elucidating the underlying metabolic and signaling mechanisms, it offers a novel dietary strategy to optimize vaccine efficacy and immune readiness.

• Alpha-Ketoglutarate in Metabolic Reprogramming Research

  2026-07-29

  Alpha-ketoglutarate (α-KGA) serves as a pivotal TCA cycle intermediate, enabling precise modeling of metabolic reprogramming and immune modulation in cancer. Explore how APExBIO's high-purity α-KGA empowers advanced enzyme system studies and immune microenvironment assays, with stepwise troubleshooting and protocol optimization.

• AMG 9810: TRPV1 Antagonist Workflows & Troubleshooting in Pa

  2026-07-28

  AMG 9810 is a benchmark TRPV1 antagonist enabling precise studies of pain mechanisms and sensory neuron signaling, with proven nanomolar potency in capsaicin-triggered assays. This guide details advanced protocols, troubleshooting strategies, and practical insights based on both foundational research and the latest metabolic stress findings.

• Digoxin as a Na+/K+ ATPase Pump Inhibitor in Research Workfl

  2026-07-28

  Digoxin's dual utility as a potent Na+/K+ ATPase pump inhibitor positions it at the forefront of both cardiovascular and antiviral research. This guide details optimized protocols, real-world troubleshooting, and actionable insights for leveraging Digoxin (APExBIO, SKU B7684) in advanced experimental models.

8138 records 8/543 page Previous Next First page 上5页 678910 下5页 Last page